Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.30
-0.04 (-0.63%)
At close: Feb 13, 2026
Daan Gene Market Cap
Daan Gene has a market cap or net worth of 8.84 billion as of February 13, 2026. Its market cap has increased by 12.10% in one year.
Market Cap
8.84B
Enterprise Value
8.32B
Revenue
765.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.30
Market Cap Chart
Since August 9, 2004, Daan Gene's market cap has increased from 1.30B to 8.84B, an increase of 579.27%. That is a compound annual growth rate of 9.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.84B | 5.70% |
| Dec 31, 2025 | 8.36B | 4.93% |
| Dec 31, 2024 | 7.97B | -41.32% |
| Dec 29, 2023 | 13.59B | -37.79% |
| Dec 30, 2022 | 21.84B | -22.43% |
| Dec 31, 2021 | 28.15B | -6.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Olymvax Biopharmaceuticals | 10.14B |
| Bio-Thera Solutions | 10.04B |
| Youcare Pharmaceutical Group | 9.69B |
| Chengdu Kanghua Biological Products | 9.23B |
| Sino Biological,Inc. | 9.00B |
| Shanghai Medicilon | 8.81B |
| Anhui Huaheng Biotechnology | 8.81B |
| Jiangxi Fushine Pharmaceutical | 8.66B |